Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma
Article in BMC Health Services Research (May 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in BMC Health Services Research (May 2024)
Article in Therapeutic Advances in Gastroenterology (January 2024)
Article in BMJ Global Health (November 2023)